RPS6-IN-1

Product Specifications

Target

Bcl-2 Family|||Caspase|||PARP|||Apoptosis|||Autophagy|||MDM-2/p53

Related Pathways

DNA Damage/DNA Repair|||Proteases/Proteasome|||Autophagy|||Apoptosis|||Chromatin/Epigenetic

Bioactivity

RPS6-IN-1 (Compound 22o) inhibits cell migration and induces apoptosis (increasing the expression of Bax, p53, cleaved-caspase 3, and cleaved-PARP) . It reduces mitochondrial membrane potential and activates autophagy (Autophagy) through the PI3K-Akt-mTOR signaling pathway, damaging mitochondria and lysosomes within the cell and causing endoplasmic reticulum stress. RPS6-IN-1 also inhibits the phosphorylation of RPS6. Notably, RPS6-IN-1 is a low systemic toxicity anticancer agent.